Table 5.

Summary of neuronal population quantification, L-GABAergic cell size measurements, and of the GABAergic axon parameters.

	T3−			T3+			T3−× T3+	Drug × T3
	Mean ± s.e.m.	n	P#	Mean ± s.e.m.	n	P#	P*	P&
L-GABA (cells/mm2)
Control	4.4 ± 0.4	60		4.4 ± 0.3	60		0.937
BDNF	4.7 ± 0.4	60	0.643	5 ± 1	50	0.253	0.138	0.255
K252a	5.1 ± 0.5	60	0.603	5.1 ± 0.5	60	0.338	0.739	0.806
Rapamycin	5.6 ± 0.4	60	0.070	4.4 ± 0.5	50	0.803	0.078	0.163
			0.310			0.308
non-GABA (cells/mm2)
Control	708 ± 46	60		521 ± 29	60		0.003
BDNF	569 ± 38	60	0.029	465 ± 36	50	0.129	0.074	0.543
K252a	763 ± 53	60	0.605	553 ± 31	60	0.537	0.004	0.939
Rapamycin	967 ± 72	60	0.007	618 ± 51	50	0.326	<0.001	0.398
			<0.001			0.095
GABA SOMA SIZE (μm2)
Control	308 ± 7	120		351 ± 8	120		<0.001
BDNF	308 ± 6	120	0.835	348 ± 6	120	0.572	<0.001	0.825
K252a	246 ± 4	120	<0.001	264 ± 5	120	<0.001	0.004	0.300
Rapamycin	187 ± 4	120	<0.001	241 ± 4	120	<0.001	<0.001	<0.001
			<0.001			<0.001
GABA AXON LENGTH (μm/field)
Control	951 ± 40	60		715 ± 42	60		<0.001
BDNF	994 ± 42	60	0.657	762 ± 47	60	0.487	0.001	0.703
K252a	1020 ± 50	60	0.300	943 ± 38	60	<0.001	0.397	0.027
Rapamycin	676 ± 28	60	<0.001	624 ± 44	60	0.160	0.312	0.009
			<0.001			<0.001
GABA BOUTONS (counts/field)
Control	47 ± 3	60		64 ± 5	60		0.009
BDNF	67 ± 3	60	<0.001	74 ± 6	60	0.309	0.836	0.038
K252a	58 ± 3	60	0.009	83 ± 3	60	<0.001	<0.001	0.174
Rapamycin	58 ± 3	60	0.003	76 ± 6	60	0.282	0.200	0.244
			<0.001			0.023
			MW-RST			MW-RST		2w-ANOVA
			ANOVA			ANOVA

Statistics as in Table 4. n, number of fields analyzed per condition.